These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9825109)

  • 1. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
    Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime.
    Crawford ED; Berger NS; Davis MA; Donohue RE
    J Urol; 1992 Apr; 147(4):1053-5. PubMed ID: 1313116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 7. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E; Bartoletti R; Trinchieri A; Rizzo M
    J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group.
    Mattina R; Cocuzza CE; Cesana M
    Infection; 1993; 21(2):106-11. PubMed ID: 8387963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolones for short-term treatment of uncomplicated urinary tract infection.
    Kadiri S; Ajayi SO; Toki RA
    East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose UTI prophylaxis in transurethral surgery. Oral ofloxacin vs parenteral cefotaxime.
    Madsen PO; Malek GH; Kahn JB
    Drugs; 1995; 49 Suppl 2():480-2. PubMed ID: 8549408
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%.
    Tabbara KF; El-Sheikh HF; Islam SM; Hammouda E
    Eur J Ophthalmol; 1999; 9(4):269-75. PubMed ID: 10651190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection.
    Klimberg IW; Cox CE; Fowler CL; King W; Kim SS; Callery-D'Amico S
    Urology; 1998 Apr; 51(4):610-5. PubMed ID: 9586615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
    Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection in the elderly: studies with lomefloxacin.
    Crome P; Bruce-Jones P
    Am J Med; 1992 Apr; 92(4A):126S-129S. PubMed ID: 1316062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antibiotic prophylaxis can influence the inflammatory response in aortic aneurysm repair: results of a randomized clinical study.
    Holzheimer RG
    J Chemother; 2003 Apr; 15(2):157-64. PubMed ID: 12797394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of a new drug, lomefloxacin (maxaquin), from the fluoroquinolone group in the treatment of patients with wound infection].
    Blatun LA; Grishina IA; Svetukhin AM; Iakovlev VP
    Antibiot Khimioter; 1994 Apr; 39(4):37-9. PubMed ID: 7826173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of fluoroquinolones in treating pneumonia in the elderly].
    Belousov IuB; Efremenkova OV; Sokolov AV; Tishenkova IF
    Antibiot Khimioter; 1999; 44(12):23-6. PubMed ID: 10687030
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of the etiologic structure of urinary tract infection and antibiotic-resistance of its pathogens].
    Derevianko II; Khodyreva LA
    Antibiot Khimioter; 1997; 42(9):27-32. PubMed ID: 9412416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV
    Urologiia; 2002; (1):11-4. PubMed ID: 11877963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical and microbiological study of the preparation perfloxacin in treating urologic infections].
    Dragiev D; Savov E; Lilov A; Tsenova Z; Saltirov I; Atanasova I
    Khirurgiia (Sofiia); 1993; 46(4):49-51. PubMed ID: 8041098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.